Generic Vancomycin Enriches Resistant Subpopulations of Staphylococcus aureus after Exposure in a Neutropenic Mouse Thigh Infection Model

Generic Vancomycin Products Fail In Vivo despite Being Pharmaceutical Equivalents of the Innovator

(2010) O. Vesga et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro and in vivo comparison of the anti-staphylococcal efficacy of generic products and the innovator of oxacillin

(2010) Carlos A Rodriguez et al.   BMC INFECTIOUS DISEASES

Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

(2010) B. P. Howden et al.   CLINICAL MICROBIOLOGY REVIEWS

Clinical, microbiologic, and genetic determinants of persistent methicillin-resistant Staphylococcus aureus bacteremia

(2010) Elizabeth A. Neuner et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin

(2010) Y. K. Yoon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Determination of Therapeutic Equivalence of Generic Products of Gentamicin in the Neutropenic Mouse Thigh Infection Model

(2010) Andres F. Zuluaga et al.   PLoS One

Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia

(2009) Carlos A. Rodriguez et al.   JOURNAL OF INFECTION

Therapeutic Monitoring of Vancomycin in Adults

(2009) Michael J Rybak et al.   PHARMACOTHERAPY